September 19 2023, 09:00 BST
Aparito, a digital health technology company, and Garmin, a leading global provider of smartwatches, fitness trackers and digital health solutions, have ratified their collaboration to integrate Garmin smartwatches into Aparito’s Atom5™ clinical trial platform. The collaboration aims to capture real-world data and develop new digital endpoints and will be managed by the Garmin Health enterprise business solutions team.
The integration of Garmin smartwatches with the Aparito Atom5™ platform allows patients to perform clinical outcome assessments (COAs) at home such as the six-minute walk test (6MWT), and passively capture data such as sleep, heart rate and activity levels, making clinical trials more accessible to patients and providing richer data to clinicians utilizing an integration of the Garmin Health SDK.
Dr. Elin Haf Davies, Aparito CEO, said, “We collaborated with Garmin due to the integrity of their Health SDK and their collaborative culture. Working together to connect Garmin devices directly to our applications ensures we get access to raw data rather than relying on black box metrics and algorithms.”
“A strong network of technology collaborators is essential for us – especially in the research and clinical trials space. Together with Aparito, we are glad to provide a solution to researchers and clinicians for unique access to physiological data that is both digital and scalable,” said Dr. Leon Brudy, Garmin Health Business Development Manager.
Ongoing collaborations between Aparito and Garmin are in place across many projects, including early-phase clinical trials, registry studies and digital biomarker development.
Join Aparito and Garmin Health at SCOPE Europe in Barcelona this October 17 and 18 where they will share their progress in digitising the 6-Minute Walk Test in conjunction with Dr. Joe Newman from Royal Papworth Hospital and the PHA UK patient group.
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials with innovative treatments.
Clinical trials can be conducted within patients’ homes by leveraging our Atom5™ platform incorporating disease-specific smartphone apps, video assessments and wearable technology to digitise clinical trials using novel eCOA and generate continuous real-world data.
Aparito’s patient-generated data platform is disease-agnostic and scalable, ready for rapid deployment in global rare disease studies.
About Garmin Health
Garmin Health provides custom enterprise business solutions that leverage Garmin’s extensive wearable portfolio and high-quality sensor data for applications in the corporate wellness, population health, and patient monitoring markets. The Garmin Health API allows third parties to ask customers to share their data in accordance with their specific privacy policies.
As part of a global company that designs, manufactures and ships products worldwide, Garmin Health supports its customers’ commerce and logistics needs, allowing enterprises to scale with a single, trusted provider. For more information, email Garmin’s press team, connect on LinkedIn, or visit online at garmin.com/health.